Fournier's Gangrene Associated With Ertugliflozin.
M. Fritz
TLDR
It is reiterated the importance of awareness of Fournier's gangrene as a potential adverse event of sodium-glucose cotransporter-2 inhibitors, including ertugliflozin, including ertugliflozin.
摘要
To describe a case of Fournier's gangrene associated with ertugliflozin. A 51-year-old male was admitted due to scrotal pain, urinary urgency, and subjective infectious symptoms. He was diagnosed with Fournier's gangrene, likely related to patient's home medication of ertugliflozin. Management and hospital course included antimicrobial and antifungal courses and was complicated by numerous surgical debridements by the urology team. After over 2 weeks, patient was discharged to rehabilitation facility. This report reiterates the importance of awareness of Fournier's gangrene as a potential adverse event of sodium-glucose cotransporter-2 inhibitors, including ertugliflozin.